Annual Gross Profit
$5.55 M
-$1.25 M-18.44%
December 31, 2023
Summary
- As of February 18, 2025, RSLS annual gross profit is $5.55 million, with the most recent change of -$1.25 million (-18.44%) on December 31, 2023.
- During the last 3 years, RSLS annual gross profit has fallen by -$714.00 thousand (-11.40%).
- RSLS annual gross profit is now -40.38% below its all-time high of $9.30 million, reached on December 31, 2019.
Performance
RSLS Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Gross Profit
$1.44 M
+$305.00 K+26.90%
September 30, 2024
Summary
- As of February 18, 2025, RSLS quarterly gross profit is $1.44 million, with the most recent change of +$305.00 thousand (+26.90%) on September 30, 2024.
- Over the past year, RSLS quarterly gross profit has stayed the same.
- RSLS quarterly gross profit is now -49.63% below its all-time high of $2.86 million, reached on June 30, 2019.
Performance
RSLS Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Gross Profit
$5.58 M
+$151.00 K+2.78%
September 30, 2024
Summary
- As of February 18, 2025, RSLS TTM gross profit is $5.58 million, with the most recent change of +$151.00 thousand (+2.78%) on September 30, 2024.
- Over the past year, RSLS TTM gross profit has stayed the same.
- RSLS TTM gross profit is now -40.03% below its all-time high of $9.30 million, reached on December 31, 2019.
Performance
RSLS TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Gross Profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
RSLS Gross Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -18.4% | 0.0% | 0.0% |
| 3 y3 years | -11.4% | 0.0% | 0.0% |
| 5 y5 years | +1152.4% | 0.0% | 0.0% |
RSLS Gross Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -33.5% | at low | -31.5% | +26.9% | -33.2% | +5.2% |
| 5 y | 5-year | -40.4% | at low | -37.0% | +71.9% | -40.0% | +5.2% |
| alltime | all time | -40.4% | -100.0% | -49.6% | +9693.3% | -40.0% | -100.0% |
ReShape Lifesciences Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.44 M(+26.9%) | $5.58 M(+2.8%) |
| Jun 2024 | - | $1.13 M(-2.7%) | $5.43 M(-1.1%) |
| Mar 2024 | - | $1.17 M(-36.8%) | $5.49 M(-1.1%) |
| Dec 2023 | $5.55 M(-18.4%) | $1.84 M(+43.0%) | $5.55 M(+4.6%) |
| Sep 2023 | - | $1.29 M(+7.9%) | $5.31 M(-13.3%) |
| Jun 2023 | - | $1.19 M(-2.5%) | $6.12 M(-10.1%) |
| Mar 2023 | - | $1.22 M(-23.5%) | $6.81 M(+0.1%) |
| Dec 2022 | $6.80 M(-18.5%) | $1.60 M(-23.8%) | $6.80 M(-2.5%) |
| Sep 2022 | - | $2.10 M(+11.6%) | $6.98 M(-0.5%) |
| Jun 2022 | - | $1.88 M(+54.6%) | $7.01 M(-3.7%) |
| Mar 2022 | - | $1.22 M(-31.4%) | $7.28 M(-12.8%) |
| Dec 2021 | $8.35 M(+33.3%) | $1.78 M(-16.8%) | $8.35 M(+1.6%) |
| Sep 2021 | - | $2.13 M(-0.8%) | $8.21 M(-1.7%) |
| Jun 2021 | - | $2.15 M(-5.7%) | $8.36 M(+18.7%) |
| Mar 2021 | - | $2.28 M(+39.2%) | $7.04 M(+12.5%) |
| Dec 2020 | $6.26 M(-32.7%) | $1.64 M(-28.1%) | $6.26 M(-7.0%) |
| Sep 2020 | - | $2.28 M(+172.5%) | $6.74 M(+2.7%) |
| Jun 2020 | - | $837.00 K(-44.3%) | $6.56 M(-23.5%) |
| Mar 2020 | - | $1.50 M(-28.9%) | $8.58 M(-7.8%) |
| Dec 2019 | $9.30 M(+2000.5%) | $2.12 M(+0.6%) | $9.30 M(+23.0%) |
| Sep 2019 | - | $2.10 M(-26.4%) | $7.56 M(+38.9%) |
| Jun 2019 | - | $2.86 M(+28.1%) | $5.45 M(+109.8%) |
| Mar 2019 | - | $2.23 M(+499.7%) | $2.60 M(+485.8%) |
| Dec 2018 | $443.00 K(+87.8%) | $372.00 K(-2580.0%) | $443.00 K(+294.5%) |
| Sep 2018 | - | -$15.00 K(-314.3%) | $112.30 K(-58.8%) |
| Jun 2018 | - | $7000.00(-91.1%) | $272.80 K(-10.4%) |
| Mar 2018 | - | $79.00 K(+91.3%) | $304.40 K(+29.0%) |
| Dec 2017 | $235.90 K(-33.6%) | $41.30 K(-71.6%) | $235.90 K(-4.5%) |
| Sep 2017 | - | $145.50 K(+276.9%) | $247.10 K(-1.8%) |
| Jun 2017 | - | $38.60 K(+267.6%) | $251.70 K(-24.6%) |
| Mar 2017 | - | $10.50 K(-80.0%) | $333.80 K(-6.0%) |
| Dec 2016 | $355.20 K | $52.50 K(-65.0%) | $355.20 K(-6.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2016 | - | $150.10 K(+24.4%) | $380.80 K(+40.3%) |
| Jun 2016 | - | $120.70 K(+278.4%) | $271.40 K(+36.5%) |
| Mar 2016 | - | $31.90 K(-59.2%) | $198.90 K(+19.1%) |
| Dec 2015 | $167.00 K(>+9900.0%) | $78.10 K(+91.9%) | $167.00 K(+87.9%) |
| Sep 2015 | - | $40.70 K(-15.6%) | $88.90 K(+84.4%) |
| Jun 2015 | - | $48.20 K(>+9900.0%) | $48.20 K(>+9900.0%) |
| Mar 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2013 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2013 | - | $0.00(0.0%) | $42.40 K(-47.0%) |
| Dec 2012 | $80.00 K(>+9900.0%) | $0.00(0.0%) | $80.00 K(0.0%) |
| Sep 2012 | - | $0.00(-100.0%) | $80.00 K(0.0%) |
| Jun 2012 | - | $42.40 K(+12.8%) | $80.00 K(+112.8%) |
| Mar 2012 | - | $37.60 K(>+9900.0%) | $37.60 K(>+9900.0%) |
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2009 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2009 | - | $0.00 | $0.00 |
| Dec 2008 | $0.00 | - | - |
FAQ
- What is ReShape Lifesciences annual gross profit?
- What is the all time high annual gross profit for ReShape Lifesciences?
- What is ReShape Lifesciences annual gross profit year-on-year change?
- What is ReShape Lifesciences quarterly gross profit?
- What is the all time high quarterly gross profit for ReShape Lifesciences?
- What is ReShape Lifesciences quarterly gross profit year-on-year change?
- What is ReShape Lifesciences TTM gross profit?
- What is the all time high TTM gross profit for ReShape Lifesciences?
- What is ReShape Lifesciences TTM gross profit year-on-year change?
What is ReShape Lifesciences annual gross profit?
The current annual gross profit of RSLS is $5.55 M
What is the all time high annual gross profit for ReShape Lifesciences?
ReShape Lifesciences all-time high annual gross profit is $9.30 M
What is ReShape Lifesciences annual gross profit year-on-year change?
Over the past year, RSLS annual gross profit has changed by -$1.25 M (-18.44%)
What is ReShape Lifesciences quarterly gross profit?
The current quarterly gross profit of RSLS is $1.44 M
What is the all time high quarterly gross profit for ReShape Lifesciences?
ReShape Lifesciences all-time high quarterly gross profit is $2.86 M
What is ReShape Lifesciences quarterly gross profit year-on-year change?
Over the past year, RSLS quarterly gross profit has changed by $0.00 (0.00%)
What is ReShape Lifesciences TTM gross profit?
The current TTM gross profit of RSLS is $5.58 M
What is the all time high TTM gross profit for ReShape Lifesciences?
ReShape Lifesciences all-time high TTM gross profit is $9.30 M
What is ReShape Lifesciences TTM gross profit year-on-year change?
Over the past year, RSLS TTM gross profit has changed by $0.00 (0.00%)